Phase I trial of capecitabine and gemcitabine with radiotherapy in locally advanced pancreatic cancer

被引:0
|
作者
Leong, T.
Michael, M.
Price, T.
Ganju, V
Strickland, A.
Jefford, M.
Muller, A.
Ngan, S.
Milner, A.
Zalcberg, J.
机构
[1] Adelaide Radiotherapy Ctr, Adelaide, SA, Australia
[2] Monash Med Ctr, Melbourne, Vic, Australia
[3] Frankston Hosp, Frankston, Vic, Australia
[4] Queen Elizabeth Med Ctr, Adelaide, SA, Australia
[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:34 / 34
页数:1
相关论文
共 50 条
  • [1] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: final results
    Michael, M.
    Price, T.
    Leong, T.
    Ganju, V.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 272 - 272
  • [2] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: interim results
    Leong, T.
    Michael, M.
    Ganju, V.
    Price, T.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Zalcberg, J.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 222 - 222
  • [3] A phase I trial of Capecitabine plus Gemcitabine with radical radiation for locally advanced pancreatic cancer
    Michael, M.
    Price, T.
    Ngan, S. Y.
    Ganju, V.
    Strickland, A. H.
    Muller, A.
    Khamly, K.
    Milner, A. D.
    Dilulio, J.
    Matera, A.
    Zalcberg, J. R.
    Leong, T.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (01) : 37 - 43
  • [4] A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer
    M Michael
    T Price
    S Y Ngan
    V Ganju
    A H Strickland
    A Muller
    K Khamly
    A D Milner
    J Dilulio
    A Matera
    J R Zalcberg
    T Leong
    [J]. British Journal of Cancer, 2009, 100 : 37 - 43
  • [5] A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    M Ikeda
    S Okada
    K Tokuuye
    H Ueno
    T Okusaka
    [J]. British Journal of Cancer, 2002, 86 : 1551 - 1554
  • [6] A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    Ikeda, M
    Okada, S
    Tokuuye, K
    Ueno, H
    Okusaka, T
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (10) : 1551 - 1554
  • [7] Phase I trial of capecitabine (CAP) and gemcitabine (GEM) with concurrent radical radiotherapy in locally advanced pancreatic cancer (PAC): Initial results
    Michael, Michael
    Leong, Trevor
    Price, Timothy J.
    Ganju, Vinod
    Strickland, Andrew
    Jefford, Michael
    Muller, Anna
    Ngan, Sam
    Milner, Alvin
    Zalcberg, John R.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 311 - 311
  • [8] Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer (LAPC)
    Skinner, Heath Devin
    Javle, Milind M.
    Wolff, Robert A.
    Clemons, Marilyn V.
    Munsell, Mark F.
    Delclos, Marc E.
    Fleming, Jason B.
    Das, Prajnan
    Crane, Christopher H.
    Krishnan, Sunil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer
    Crane, CH
    Ellis, LM
    Abbruzzese, JL
    Amos, C
    Xiong, HQ
    Ho, L
    Evans, DB
    Tamm, EP
    Ng, C
    Pisters, PWT
    Charnsangavej, C
    Delclos, ME
    O'Reilly, M
    Lee, JE
    Wolff, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1145 - 1151
  • [10] Phase I Trial of Gemcitabine Dose Escalation with Concurrent Radiotherapy for Patients with Locally Advanced Pancreatic Cancer
    Nishida, Tsutomu
    Tsutsui, Shusaku
    Yamamoto, Katsumi
    Konishi, Koji
    Hayashi, Yoshito
    Iijima, Hideki
    Tsujii, Masahiko
    Takeda, Yutaka
    Kitagawa, Toru
    Yoshioka, Yasuo
    Inoue, Takehiro
    Hayashi, Norio
    [J]. PANCREATOLOGY, 2010, 10 (01) : 60 - 65